GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 15.634
EU - Europa 6.915
AS - Asia 2.460
AF - Africa 34
SA - Sud America 25
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.085
Nazione #
US - Stati Uniti d'America 15.586
GB - Regno Unito 2.940
IT - Italia 1.175
CN - Cina 868
SE - Svezia 834
SG - Singapore 609
DE - Germania 556
UA - Ucraina 548
HK - Hong Kong 390
TR - Turchia 382
FI - Finlandia 277
BG - Bulgaria 222
FR - Francia 69
RU - Federazione Russa 42
IE - Irlanda 40
IN - India 38
ID - Indonesia 33
LT - Lituania 32
ES - Italia 28
CA - Canada 27
IR - Iran 24
NL - Olanda 23
BE - Belgio 20
PL - Polonia 20
MX - Messico 19
RO - Romania 19
EG - Egitto 18
JP - Giappone 18
PH - Filippine 17
PK - Pakistan 15
AU - Australia 12
KR - Corea 12
MY - Malesia 12
VN - Vietnam 12
CZ - Repubblica Ceca 8
PE - Perù 8
HU - Ungheria 7
BR - Brasile 6
CH - Svizzera 6
GR - Grecia 6
IL - Israele 6
PT - Portogallo 6
IQ - Iraq 5
YE - Yemen 5
AT - Austria 4
CL - Cile 4
EE - Estonia 4
JO - Giordania 4
MD - Moldavia 4
RS - Serbia 4
BD - Bangladesh 3
EU - Europa 3
GH - Ghana 3
MK - Macedonia 3
NG - Nigeria 3
SI - Slovenia 3
TH - Thailandia 3
TZ - Tanzania 3
AL - Albania 2
AR - Argentina 2
BZ - Belize 2
CO - Colombia 2
DK - Danimarca 2
KE - Kenya 2
MA - Marocco 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UG - Uganda 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EC - Ecuador 1
IS - Islanda 1
ME - Montenegro 1
SA - Arabia Saudita 1
SM - San Marino 1
ZA - Sudafrica 1
Totale 25.085
Città #
Southend 2.535
Fairfield 2.494
Woodbridge 1.618
Ashburn 1.264
Houston 1.261
Jacksonville 1.184
Chandler 1.040
Seattle 909
Wilmington 825
Ann Arbor 772
Cambridge 751
Dearborn 678
Nyköping 534
Hong Kong 384
Modena 318
Beijing 285
Singapore 279
Princeton 242
San Diego 235
Sofia 219
Eugene 193
Izmir 161
Helsinki 91
London 79
Bremen 67
Redwood City 65
Des Moines 62
Milan 55
Shanghai 54
Bologna 50
Rome 43
Norwalk 42
Dublin 38
Falls Church 37
Boardman 33
New York 29
Dongguan 23
Guangzhou 23
Hefei 23
Kilburn 23
Philadelphia 23
Parma 22
Jakarta 20
Chiswick 18
Hounslow 18
San Mateo 18
Kunming 17
Brussels 16
Nanjing 16
Indiana 15
Brescia 14
Istanbul 14
Turin 14
Auburn Hills 13
Florence 13
Jinan 13
Naples 13
Verona 13
Dong Ket 12
Palermo 12
Briona 11
Paris 11
Saint Petersburg 11
Cagliari 10
Frankfurt am Main 10
Amsterdam 9
Los Angeles 9
Cairo 8
Lima 8
Mountain View 8
Acton 7
Berlin 7
Fuzhou 7
Nanchang 7
Pontedera 7
Pune 7
Quezon City 7
Ravenna 7
Bari 6
Monmouth Junction 6
Moscow 6
Prato 6
Prescot 6
Southwark 6
Sydney 6
Ardabil 5
Athens 5
Augusta 5
Bergamo 5
Borgosesia 5
Castelfranco Veneto 5
Chicago 5
Dallas 5
Forlì 5
Genoa 5
Grafing 5
Hamilton 5
Hebei 5
Henderson 5
Karachi 5
Totale 19.600
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 596
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 253
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 216
Inositol as putative integrative treatment for PCOS 216
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 186
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 181
Diagnostic and therapeutic approach to hypothalamic amenorrhea. 180
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 180
Use of metformin in the treatment of polycystic ovary syndrome 179
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 179
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 179
Inositol and human reproduction. From cellular metabolism to clinical use 176
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 174
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 173
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 170
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 170
Advances in neurosteroids: Role in clinical practice 167
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 167
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 164
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 161
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 161
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 160
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 159
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 159
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 157
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 156
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 156
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 154
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 153
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 153
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 153
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 153
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 153
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 152
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 152
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 152
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 148
Hypothalamic amenorrhea in a Camurati-Engelmann disease-a case report 147
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 147
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 147
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 146
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 146
Effects of red clover extracts on breast cancer cell migration and invasion 145
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 144
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 143
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 143
Episodic secretion of activin A in pregnant women 141
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 141
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 141
Bollettino di Endocrinologia Ginecologica 140
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 140
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 139
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 139
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 138
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 138
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 137
Adrenal function under long-term raloxifene administration 137
Estetrol modulates endothelial nitric oxide synthesis in human endothelial cells 137
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 136
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 136
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome 136
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 135
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 135
Obesità e benessere: i rischi per la salute della donna obesa 134
Corticotropin-releasing factor-binding protein: Origins and possible functions 134
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 133
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 132
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 132
Tibolone, transdermal estradiol or oral estrogen-progestin therapies: Effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels 132
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 131
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 131
Kisspeptin and LH pulsatile temporal coupling in PCOS patients 130
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 129
Female precocious puberty, obesity and polycystic-like ovaries 129
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 129
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 129
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 128
Allopregnanolone concentrations and premenstrual syndrome 128
. Opioid control of gonadotrophin secretion in humans. 128
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 128
Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells 127
Life events impact in patients with secondary amenorrhoea. 126
Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. 126
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 126
Long-term low dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. 126
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 125
Contraception as prevention and therapy: sex steroids and the brain 125
The transition from pubertal development to postmenopause discloses a gonadotropin-releasing hormone-independent mechanism regulating follicle-stimulating hormone release 125
Estrogens as neuromodulators 125
Endocrinologia Ginecologica 124
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 124
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 124
Polycystic ovary syndrome: A new ultrasonographic and color Doppler pattern 124
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 123
Which form of HRT should we choose? 122
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts 122
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 121
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 121
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 121
Progestinici e fibromatosi uterina 119
Totale 15.045
Categoria #
all - tutte 120.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.625


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.307 0 0 0 399 633 793 808 475 506 168 309 216
2020/20214.162 366 133 288 330 469 297 392 723 131 572 218 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/2025632 334 106 80 112 0 0 0 0 0 0 0 0
Totale 25.403